Tyson Foods Inc. (TSN-N)

It could benefit from the popular wight-loss drugs, because those drugs actually remove protein as well as fat. Those who take these drugs must consume more protein, which is how Tyson benefits.

They report Monday. Costs for beef and chicken have declined, which should lower their costs, but is TSX organized enough to profit from it? TSN has been a major slump. He doubts it.

TSN pays a good yield of 4%, and management has grown its dividends nicely over the past 10 years. Sales growth is expected to be modest in the next few years (low single digits), and it generates a good level of operating cash flows. Its margins have contracted over the past 12 months, and it has missed on its five past earnings results. Its balance sheet is strong, with a good cash balance of $706M and an equity position of $18.9B. It has its strengths and operates in a defensive sector. We would be comfortable with this name for income, but we do not expect much in the way of growth in the near to intermediate term. 
Unlock Premium - Try 5i Free

It reports Monday. Must listen to their conference call to determine food inflation. But this stock has disappointed so often in the past.